Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07124390 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electroacupuncture as a Treatment for Refractory Overactive Bladder

Study acronym: EAOAB
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Jul 30, 2027 → Nov 30, 2027
Primary endpoints added 2 → 5 primary endpoints
Enrollment reduced 25% 32 → 24 participants
See other at-risk trials from Chelsea and Westminster NHS Foundation Trust

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modifiedv3 Show 10 more changesShow less
    • Recruitment opened
    • Primary completion pushed from Jul 30, 2027 to Nov 30, 2027
    • Enrollment reduced: 32 → 24 participants
    • Study completion pushed from Jul 30, 2027 to Dec 30, 2027
    • Interventions modified
    • Trial arms changed: 3 → 2
    • Start date changed from estimate of Jul 1, 2026 to Aug 15, 2026
    • Secondary endpoints: 3 to 4
    • Study description expanded, about 9 words
    • Site details revised
  2. Enrollment target: 60 to 32v2 Show 7 more changesShow less
    • Start date: Feb 20, 2026 to Jul 1, 2026
    • Primary endpoints: 3 to 2
    • Primary completion date: May 20, 2027 to Jul 30, 2027
    • Study completion date: Jun 20, 2027 to Jul 30, 2027
    • Secondary endpoints: 7 to 3
    • Study description shortened, about 3,952 words
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a single-site feasibility randomised controlled trial evaluating the feasibility and acceptability of electroacupuncture (EA), and percutaneous tibial nerve stimulation (PTNS), in women with refractory overactive bladder (OAB) who have not achieved satisfactory improvement following standard pelvic health physiotherapy. The primary aim is to determine whether a larger definitive trial is feasible by assessing recruitment, consent, retention, treatment adherence, data completeness, intervention delivery, safety, and participant acceptability. Twenty-four participants will be randomly allocated to receive electroacupuncture or PTNS, over a 12-week treatment period. Outcome assessments will be completed at baseline, 6 weeks, 12 weeks, 6 months, and 12 months. The findings will inform the design of a future definitive randomised controlled trial and contribute to the evidence base for non-pharmacological treatment options for overactive bladder.
Trial Details
NCT Number NCT07124390
Lead Sponsor Chelsea and Westminster NHS Foundation Trust
Collaborators: Imperial College London
Conditions
(from sponsor)		 Over Active Bladder, Urinary Incontinence (UI), Nocturia
Related terms Nocturia, Urinary Incontinence
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov